[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.171.146.16. Please contact the publisher to request reinstatement.
[Skip to Content Landing]

Year

Day

July 31, 2019
Original Investigation

Association of Vitamin A Intake With Cutaneous Squamous Cell Carcinoma Risk in the United States

Abstract Full Text
free access
JAMA Dermatol. Published online July 31, 2019. doi:10.1001/jamadermatol.2019.1937

This cohort study examines whether vitamin A intake is associated with cutaneous squamous cell carcinoma risk among US adults.

Association of Filaggrin Loss-of-Function Variants With Race in Children With Atopic Dermatitis

Abstract Full Text
JAMA Dermatol. Published online July 31, 2019. doi:10.1001/jamadermatol.2019.1946

This registry cohort study describes and compares results of targeted sequencing of FLG loss-of-function variants in US children of African and European ancestry and the association of these variants with onset and persistence of atopic dermatitis.

Observation

Lichen Planus Follicularis Tumidus Associated With PD-1 Blockade

Abstract Full Text
JAMA Dermatol. Published online July 31, 2019. doi:10.1001/jamadermatol.2019.1676

This case report describes a patient with a rare type of immune-related cutaneous adverse event following anti–PD-1 therapy for melanoma.

July 24, 2019
Images in Dermatology

Necrolytic Migratory Erythema

Abstract Full Text
JAMA Dermatol. Published online July 24, 2019. doi:10.1001/jamadermatol.2019.1658

This case report describes a man in his 40s who presented with a 7-year history of a pruritic, annular cutaneous eruption and flaccid vesicles and was diagnosed with glucagonoma syndrome and associated necrolytic migratory erythema.

Observation

Coinfection With Talaromyces marneffei and Other Pathogens Associated With Acquired Immunodeficiency

Abstract Full Text
JAMA Dermatol. Published online July 24, 2019. doi:10.1001/jamadermatol.2019.1532

This case report describes a woman in her 40s who became infected with Talaromyces marneffei and other pathogens after developing an adult-onset immunodeficiency syndrome.

July 17, 2019
Editorial

Early Strides for Necessary Data-Driven Improvement in iPLEDGE

Abstract Full Text
JAMA Dermatol. Published online July 17, 2019. doi:10.1001/jamadermatol.2019.1247
Brief Report

US Food and Drug Administration Reports of Pregnancy and Pregnancy-Related Adverse Events Associated With Isotretinoin

Abstract Full Text
free access
JAMA Dermatol. Published online July 17, 2019. doi:10.1001/jamadermatol.2019.1388

This analysis uses the FDA Adverse Event Reporting System to determine the frequency and rate of pregnancy among women taking isotretinoin and of pregnancy-related adverse events associated with isotretinoin.

July 10, 2019
Original Investigation

Evaluation of the Number-Needed-to-Biopsy Metric for the Diagnosis of Cutaneous Melanoma: A Systematic Review and Meta-analysis

Abstract Full Text
JAMA Dermatol. Published online July 10, 2019. doi:10.1001/jamadermatol.2019.1514

This systematic review and meta-analysis evaluates the worldwide variations in the number-needed-to-biopsy (NNB) metric, lack of related data on US-based dermatologists, and nonstandardized processes for reporting NNB for diagnosing cutaneous melanoma.

July 3, 2019
Original Investigation

Efficacy and Safety of Guselkumab in Japanese Patients With Palmoplantar Pustulosis: A Phase 3 Randomized Clinical Trial

Abstract Full Text
open access
JAMA Dermatol. Published online July 3, 2019. doi:10.1001/jamadermatol.2019.1394

This randomized clinical trial evaluates the efficacy and safety of guselkumab in the treatment of patients with palmoplantar pustulosis.

Psychiatric Adverse Events in Patients Taking Isotretinoin as Reported in a Food and Drug Administration Database From 1997 to 2017

Abstract Full Text
JAMA Dermatol. Published online July 3, 2019. doi:10.1001/jamadermatol.2019.1416

This study evaluates types and frequency of psychiatric adverse events that were reported to the US Food and Drug Administration’s Adverse Event Reporting System from 1997 through 2017 for patients taking isotretinoin.

×